PCDH10 and colorectal carcinoma: Dobre and colleagues further demonstrated BRAF positive cases have higher Pcdh10 methylation levels than BRAF negative cases (Dobre et al. 2021). Taken together, Pcdh10 genetic modification and epigenetic inactivation play critical roles in the development of CRC.